MasterCard Inc vs Stryker Corporation — how do they compare? MasterCard Inc trades at $538.35 (market cap $483.71B), while Stryker Corporation trades at $314.62 (market cap $122.35B). The key difference: MasterCard Inc is far larger — about 4× Stryker Corporation's market cap, and Stryker Corporation pays the higher dividend (1%). Which is the better fit depends on your goals.
| MA | SYK | |
|---|---|---|
Market Cap | $483.71B | $122.35B |
Volume | 4,635,698 | — |
Sector | Consumer Cyclical | Technology |
52-Week High | $598.96 | $403.53 |
52-Week Low | $471.55 | $282.58 |
Enterprise Value | $494.45B | $134.10B |
Dividend Yield | 0.64% | 1% |
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $538.30, down 0.97% on the day, with a bullish technical outlook supported by moving averages and strong institutional buying. The company demonstrates robust fundamentals with revenue growth from $22.2B in 2022 to $32.8B in 2025, net income margins above 45%, and consistent earnings beats. Recent news highlights AI payment initiatives and expansion into underbanked markets, reinforcing its competitive positioning.
The stock presents a compelling long-term opportunity given its profitability, growth trajectory, and dominant market position, though elevated valuation multiples (P/E 31.68) and competition from emerging payment technologies pose risks. Analyst consensus is strongly bullish with a $634.27 price target, suggesting ~18% upside from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →